Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients
Paweł Poznański, Hanna Augustyniak‐Bartosik, Anna Magiera-Żak, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2224-2224
Open Access | Times Cited: 21

Showing 21 citing articles:

Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 189-205
Open Access | Times Cited: 7
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis
Yi‐Chin Chang, Yi‐Chun Chen, Chiang-Chi Huang, et al.
International Journal of Antimicrobial Agents (2023) Vol. 62, Iss. 1, pp. 106834-106834
Open Access | Times Cited: 9
Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients
Sabina Herrera, José María Aguado, Francisco Javier Candel, et al.
Transplantation Reviews (2023) Vol. 37, Iss. 4, pp. 100788-100788
Closed Access | Times Cited: 7
Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir
Po-Chun Chen, Chiang-Chi Huang, Chung-Ming Fu, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 543-543
Open Access | Times Cited: 6
The Impact and Treatment of COVID-19 in Hemodialysis Patients
Daisuke Katagiri, Kan Kikuchi
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 838-838
Open Access | Times Cited: 5
Medication safety in chronic kidney disease
Sonal Singh
Current Opinion in Nephrology & Hypertension (2023) Vol. 32, Iss. 5, pp. 434-438
Closed Access | Times Cited: 5
Risk of severe coronavirus disease 2019 despite vaccination in patients requiring treatment with immune‐suppressive drugs: A nationwide cohort study of US Veterans
Sonia T. Anand, Austin D. Vo, Jennifer La, et al.
Transplant Infectious Disease (2023) Vol. 26, Iss. 1
Closed Access | Times Cited: 5
Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19
Zeyuan Zheng, Huimin Sun, Xiao Hu, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients
Maria A. Mendoza, Raymund R. Razonable
Infectious Disease Clinics of North America (2023) Vol. 37, Iss. 3, pp. 475-493
Open Access | Times Cited: 4
COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review
Thomas McDonnell, Henry H. L. Wu, Philip A. Kalra, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 926-926
Open Access | Times Cited: 3
Comparative outcomes of hemodialysis patients facing pre‐Omicron and Omicron COVID‐19 epidemics
Hiroko Beppu, Tatsuya Fukuda, Naoya Otsubo, et al.
Therapeutic Apheresis and Dialysis (2023) Vol. 28, Iss. 1, pp. 51-60
Closed Access | Times Cited: 3
The prevention and treatment of COVID-19 in patients treated with hemodialysis
Binyu Zeng, Jia Zhou, Daizhuang Peng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Editorial for SARS-CoV-2 and COVID-19 Topical Collection
Luis Martínez‐Sobrido, Fernando Almazán
Viruses (2024) Vol. 16, Iss. 3, pp. 356-356
Open Access
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease
Chia‐Chen Chen, Chi-Ya Huang, Jheng‐Yan Wu, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-8
Closed Access
Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study
Takashi Sakaguchi, Akihiko Mitsuke, Yoichi Osako, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort study
Wiessam Abu Ahmad, Ronen Arbel, Yael Wolff Sagy, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 10, pp. 1305-1311
Closed Access
Management of Kidney Transplant Outpatients With COVID-19: A Single Center Experience
M. Kubisova, S Sulková, Petr Moučka, et al.
Transplant International (2024) Vol. 37
Open Access
Assessment of pharmacokinetics and tolerability following single‐dose administration of molnupiravir in participants with hepatic or renal impairment
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir
Miguel Villamarín, Óscar Len
Revista Española de Quimioterapia (2023) Vol. 36, Iss. Suppl1, pp. 22-24
Open Access | Times Cited: 1
Role of Molnupiravir in the Treatment of COVID-19
Aman Sharma, Vaishali M. Patil, Meenakshi Dahiya, et al.
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access
Diabetic Kidney Disease and COVID-19
Mersema Abate, Boonyanuth N. Maturostrakul, Vinay Nair
Contemporary Endocrinology (2023), pp. 63-78
Closed Access
Page 1

Scroll to top